| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8244288 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 8 Pages |
Abstract
Conclusions: Stereotactic body radiotherapy in patients with limited-stage NSCLC resulted in a high probability of local control and a promising survival rate. The toxicity after SBRT of lung tumors was moderate. However, deterioration in performance status, respiratory insufficiency, and other side effects were observed.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Morten Ph.D., Henrik D.M.Sc., Anders Traberg B.S., Lars Ohlhuis, Jorgen B.S., Hanne M.D., Anne Kiil M.D., Cai D.M.Sc., Svend Aage D.M.Sc., Hans D.M.Sc.,